NCT01229241View on ClinicalTrials.gov

Assessment of Systemic Pharmacokinetics of Levobupivacaine and Ropivacaine During Continuous Epidural Infusion

PHASE4CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2011

Conditions
AnesthesiaSurgery
Interventions
DRUG

local anesthetic

"postoperative 48h epidural continuous infusion,~1. ropivacaine 0,2% (250ml)+ sufentanil 0,75mcg/ml~2. levobupivacaine 0,125% (250ml)+ sufentanil 0,75mcg/ml"

Trial Locations (2)

20052

Unità Operativa di Anestesia e Rianimazione - Azienda Ospedaliera San Gerardo, Monza

27100

IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER

NCT01229241 - Assessment of Systemic Pharmacokinetics of Levobupivacaine and Ropivacaine During Continuous Epidural Infusion | Biotech Hunter | Biotech Hunter